# Enpowering Progression Risk of Cerebral Amyloid Angiopathy

> **NCT06960538** · — · COMPLETED · sponsor: **Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta** · enrollment: 200 (actual)

## Conditions studied

- Cerebral Amyloid Angiopathy
- CAA - Cerebral Amyloid Angiopathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06960538
- **Lead sponsor:** Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06960538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06960538, "Enpowering Progression Risk of Cerebral Amyloid Angiopathy". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06960538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*